Less Ads, More Data, More Tools Register for FREE

PRESS: UK Inks Partnerships For Extra 90 Million Virus Vaccine Doses

Mon, 20th Jul 2020 06:52

(Alliance News) - The UK government has signed new deals which will provide more than 90 million doses of Covid-19 vaccine, according to multiple reports.

BBC Radio 4's Today programme and Sky News reported the government has secured an agreement for 30 million doses of a vaccine being developed – and currently at phase two trials – by BioNTech and German firm Pfizer Inc.

There has also been an in-principle deal done for 60 million doses of a vaccine that is being developed by France's Valneva.

The figure of 90 million is in addition to the 100 million doses of vaccine that are being developed by Oxford University in partnership with AstraZeneca PLC, as well as another at Imperial College London which started human trials in June.

UK Business Secretary Alok Sharma said the new agreements would "ensure the UK has the best chance possible of securing a vaccine that protects those most at risk".

By PA Reporter

source: PA

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company rep...

16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract c...

12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugel...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.